Leukaemia drug may prove beneficial for stroke patients as wellJune 23rd, 2008 - 1:44 pm ICT by ANI
London, June 23 (ANI): A new study has found that a drug used to treat leukaemia may also prove beneficial for stroke patients a finding that may have the potential to revolutionize the treatment of stroke.
Researchers from the Ludwig Institute for Cancer Research (LICR) and the University of Michigan Medical School have found that leukaemia drug, imatinib (Gleevec(r)) when combined with drug tPA, used to treat stroke, effectively lowered the risk of tPA-associated bleeding in mice.
The tPA drug treatment is limited use within the first three hours of the stroke onset, however the new study showed that the new drug combo reduced the bleeding risk even when tPA was given as late as five hours.
According to WHO, less than 3pct of patients with this type of stroke receive tPA because the narrow safety window has often passed by the time a stroke patient reaches a hospital and is diagnosed.
The scientists have found that key growth factor PDGF-CC, responsible for regulating cell growth, can also control the blood brain barrier (a structure that normally shields the brain from the blood).
When tPA acts on PDGF-CC, the blood-brain barrier becomes porous and can start to leak. Imatinib inhibits the detrimental effect of PDGF-CC by binding to its receptor PDGFR alpha, seemingly without hindering tPA’s therapeutic effect, which is to break down clots that have lodged in the brain’s blood vessels.
“Ten years ago our research group identified the growth factor PDGF-CC, and we are now very excited having unraveled a mechanism in the brain involving this factor”, Nature quoted lead researcher Professor Ulf Eriksson, as saying
The research team claims that if the clinical trial with stroke patients in Sweden showed positive results, then imatinib or similar drugs could be given to stroke patients to increase the therapeutic quality of tPA.
“This finding has indeed the potential to revolutionize the treatment of stroke,” Eriksson added.
The study is published in Nature Medicine. (ANI)
- MRI may predict stroke onset - Nov 03, 2010
- Clot busting drug could improve stroke treatment - May 29, 2011
- Brain may use clot-busting drug naturally to offer protection against stroke - May 06, 2010
- New technique could reverse damage caused by strokes - Dec 08, 2010
- Antibiotic could be the new stroke treatment - Oct 06, 2009
- New drug limits brain damage in stroke - Jul 27, 2012
- New hybrid drug, derived from turmeric, may benefit stroke victims - Feb 10, 2011
- Study reveals that 1 in 7 strokes take place during sleep - May 10, 2011
- Warfarin users more vulnerable to brain bleeding after stroke treatment - Mar 09, 2010
- Blood pressure drug a boon for stroke patients - Oct 23, 2011
- Aspirin safer than warfarin in preventing stroke: Study - May 03, 2012
- Novel approach for leukaemia treatment discovered - Mar 04, 2010
- Growth factor targeted by cancer drugs also prevents heart problem - Jan 12, 2010
- Compound derived from turmeric has neuroprotective effects - Dec 16, 2010
- Cholesterol-lowering drugs may improve blood flow after stroke - Apr 27, 2011
Tags: blood brain barrier, blood vessels, cancer research, clinical trial, detrimental effect, gleevec, june 23, licr, ludwig institute, michigan medical school, research group, researcher professor, shields, stroke onset, stroke patient, stroke patients, therapeutic effect, tpa, treatment of stroke, university of michigan medical school